Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, July 10, 2026
🇺🇸 FDA

insulin glargine News

🇺🇸 FDA ← All news

FDA insulin glargine coverage for business development, investment, and market access teams

Critical impact NewsMay 4, 2026

FDA Approves LANGLARA Interchangeable Biosimilar to Lantus Insulin - Lannett Company Enters Diabetes Market

FDA · Diabetes/Endocrinology · 4 min

Dr. Emily Carter
Critical impact NewsApr 17, 2026

Lilly's Foundayo Shows 57% Mortality Reduction in Landmark ACHIEVE-4 Diabetes Trial

Type 2 Diabetes with Cardiovascular Benefits · 3 min

James Chen, PharmD

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.